Brief: Cipher Pharmaceuticals announces Canadian launch of Beteflam
05/04/2016 21:00
April 5 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO
* Cipher pharmaceuticals announces canadian launch of
beteflam
* Commonly reported adverse drug reactions that occurred in
patients using beteflam were skin and subcutaneous tissue
disorders
* Expect to continue growth with six products targeted for
canadian market in 2016 and eight in 2017
Source text for Eikon: ID:nPn19s2Jfa
Further company coverage: CPH.TO
(Bengaluru Newsroom: +1-646-223-8780)
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million